Methods of treating atherosclerosis

Details for Australian Patent Application No. 2006241219 (hide)

Owner Novartis AG

Inventors Webb, Randy Lee

Agent Davies Collison Cave

Pub. Number AU-A-2006241219

PCT Pub. Number WO2006/116435

Priority 60/675,128 27.04.05 US

Filing date 25 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116435 Priority application(s): WO2006/116435

13 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006241221-Bone anchor with locking cap and method of spinal fixation

2006241210-Fused heterocyclic compounds